RUSSO, GIANLUCA
 Distribuzione geografica
Continente #
AS - Asia 2.127
EU - Europa 1.468
NA - Nord America 1.083
SA - Sud America 237
AF - Africa 33
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.953
Nazione #
SG - Singapore 1.127
US - Stati Uniti d'America 1.022
RU - Federazione Russa 659
CN - Cina 483
IT - Italia 435
HK - Hong Kong 240
BR - Brasile 193
DE - Germania 126
VN - Vietnam 103
IN - India 57
GB - Regno Unito 49
NL - Olanda 46
KR - Corea 43
FI - Finlandia 34
CA - Canada 24
MX - Messico 24
ES - Italia 22
AR - Argentina 20
UA - Ucraina 17
FR - Francia 16
BD - Bangladesh 15
PL - Polonia 14
EC - Ecuador 10
JP - Giappone 10
ZA - Sudafrica 9
AT - Austria 8
IE - Irlanda 8
IQ - Iraq 8
SE - Svezia 8
CI - Costa d'Avorio 7
PK - Pakistan 6
VE - Venezuela 6
BE - Belgio 5
ID - Indonesia 5
LT - Lituania 5
PH - Filippine 4
TR - Turchia 4
AU - Australia 3
BS - Bahamas 3
EG - Egitto 3
GR - Grecia 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
GA - Gabon 1
HU - Ungheria 1
JM - Giamaica 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
MZ - Mozambico 1
NE - Niger 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
YT - Mayotte 1
Totale 4.953
Città #
Singapore 637
Hong Kong 239
Hefei 222
Moscow 138
Ashburn 120
Beijing 115
Chandler 113
Naples 98
Santa Clara 63
Munich 51
Los Angeles 47
Ho Chi Minh City 42
Seoul 42
Milan 41
Kochi 38
Rome 34
San Jose 31
New York 28
São Paulo 28
Boardman 26
Redondo Beach 24
Dallas 20
Lawrence 20
Buffalo 19
Helsinki 18
Hanoi 16
Des Moines 15
Millbury 15
Amsterdam 14
Boston 14
Mexico City 14
The Dalles 12
Chicago 11
Poplar 11
Turku 11
Warsaw 10
Bologna 9
Frankfurt am Main 9
London 9
Montreal 9
Orem 9
Seattle 9
Valencia 9
Falkenstein 8
Florence 8
Nuremberg 8
Stockholm 8
Tokyo 8
Wilmington 8
Atlanta 7
Bari 7
Brooklyn 7
Da Nang 7
Genoa 7
Haiphong 7
Krefeld 7
Rio de Janeiro 7
Chennai 6
Denver 6
Düsseldorf 6
Guangzhou 6
Houston 6
San Francisco 6
Dublin 5
Hải Dương 5
Lappeenranta 5
Phoenix 5
Salt Lake City 5
Shanghai 5
Buenos Aires 4
Charlotte 4
Cilavegna 4
Council Bluffs 4
Johannesburg 4
Madrid 4
Monza 4
Ninh Bình 4
Sciacca 4
Tianjin 4
Toronto 4
Turin 4
Amman 3
Bad Durrheim 3
Belo Horizonte 3
Berlin 3
Bexley 3
Brasília 3
Brussels 3
Casalnuovo di Napoli 3
Cuenca 3
Curitiba 3
Fairfield 3
Fisciano 3
Grosseto 3
Guarulhos 3
Karachi 3
Kronberg 3
Lucca 3
Macerata 3
Mercato San Severino 3
Totale 2.735
Nome #
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing 160
Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens 131
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 126
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 124
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 119
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 118
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 117
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 115
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 115
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 115
Prostate health index and multiparametric mri: Partners in crime fighting overdiagnosis and overtreatment in prostate cancer 115
Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C‐mutated advanced non‐small cell lung cancer 114
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 110
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 106
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 106
The role of liquid biopsy in epithelial ovarian cancer: state of the art 104
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 103
Brca1/2 ngs somatic testing in clinical practice: a short report 102
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 101
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 101
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 101
The evolving role of liquid biopsy in lung cancer 100
Next generation sequencing in cytology 99
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 98
Methods for actionable gene fusion detection in lung cancer: now and in the future 98
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 97
Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study 93
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 92
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 91
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 91
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 91
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 89
Tumor mutational burden on cytological samples: A pilot study 89
BRAF: A Two-Faced Janus 89
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 85
The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study 82
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 81
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler 80
Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma 78
Critical aspects of MSI testing in endometrial cancer: a comparison study 76
Innovation in next-generation sequencing in non-Small cell lung cancer diagnostics 76
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 74
Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls 70
Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience 69
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 66
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 60
Recent advances in liquid biopsy for precision oncology: emerging biomarkers and clinical applications in lung cancer 60
Genomics and the early diagnosis of lung cancer 60
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer 59
Liquid biopsy testing in urological cancers: Focus on urine 58
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer 56
Smaller, cheaper, faster: where next for liquid biopsies? 53
Mutational profiling of SMARCA4 and SMARCB1 in ampullary adenocarcinoma: a preliminary study 44
Homologous recombination deficiency testing in ovarian cancer: the diagnostic experience of a referral Italian institution 43
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 32
The potential application of stroma modulation in targeting tumor cells: focus on pancreatic cancer and breast cancer models 21
Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter Study 19
Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience 1
Totale 5.023
Categoria #
all - tutte 14.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 5 12 7 9 6 6
2021/2022173 6 5 12 2 3 3 3 15 1 25 55 43
2022/2023300 26 14 17 12 46 41 1 34 45 20 41 3
2023/2024301 10 42 17 16 20 18 13 34 17 33 40 41
2024/20251.598 54 58 6 17 38 92 141 115 81 205 586 205
2025/20262.595 350 449 438 390 705 210 53 0 0 0 0 0
Totale 5.023